Vincent Rizzo: Beta Blocker Choice May Impact Portal Vein Thrombosis and Survival in Cirrhosis
Vincent Rizzo, Chief Department of Internal Medicine at Icahn School of Medicine at Mount Sinai, shared a post on LinkedIn about a recent article he and his colleagues co- authored, published in Liver International, adding:
“Latest article, just published yesterday in Liver International. large study, over 8,000 patients with potentially practice changing, meanin agful results. big, huge shoutout to the team!!!
here is the lay summary:
In patients with liver cirrhosis, beta-blockers are commonly used to reduce complications related to high blood pressure in the liver.
In this large real-world study, we found that one commonly used beta-blocker (propranolol) was associated with a higher risk of blood clots in the portal vein, while another (carvedilol) did not increase this risk and was linked to better survival.
These findings suggest that the choice of beta-blocker may significantly affect patient outcomes.”
Title: Portal Vein Thrombosis Risk in Cirrhotic Patients With Portal Hypertension on Beta-Blockers: A Multi-Institutional Cohort Study
Authors: Hazem Abosheaishaa, Khaled Elfert, Mohammed Abusuliman, Abdellatif Ismail, Abdullah Olimy, Ahmed Elsayed Alzamzamy, Ahmed Omran, Vincent Rizzo, Mahmoud Nassar, Mohamed El-Kassas
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 29, 2026, 16:03Marco De Giovanni: The Platelet – Serotonin Link Behind Severe COVID-19
-
Aug 29, 2026, 16:01FDA Approves Imaavy for wAIHA – Thalassaemia International Federation
-
Aug 29, 2026, 16:00Dianne E. van der Wal: Advancing Platelet Research at ISTH 2026 in Paris
-
Aug 29, 2026, 15:55Cory Dugan: Iron Deficiency and Anemia Across the Female Life
-
Aug 29, 2026, 15:53Melina Rodriguez: FDA Approves Imaavy as First Treatment for Warm AIHA
-
Aug 29, 2026, 15:50Karen T․: Seeking a Patient Liaison to Support the Bleeding Disorders Community
-
Aug 29, 2026, 15:49Ujjawal Agarwal: Alkem’s Fight Against Anemia in Rural Bihar
-
Aug 29, 2026, 15:44Christopher Cannon: Anticoagulation Shows Benefits Even in Low Risk Atrial Fibrillation Patients
-
Aug 29, 2026, 15:43Aniela Popescu: Heart Failure Care Enters a New Era With the 2026 ESC Guidelines